Search research articles
Contact Us
Filters
Showing results (61-70 of 144) with videos related to
Page
of 15
Sort By:
Alimentary Pharmacology & Therapeutics
|
August 29, 2002
A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia
G Holtmann, J Gschossmann, P Mayr, et al.
Gut
|
June 9, 1998
Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia
G Holtmann, H Goebell, F Jockenhoevel, et al.
Digestive Diseases and Sciences
|
August 2, 2001
H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor?
G Holtmann, J Gschossmann, M Holtmann, et al.
The Journal of Urology
|
April 1, 1995
Report of a case with giant condyloma (Buschke-Löwenstein tumor) localized in the bladder
A Wiedemann, W P Diekmann, G Holtmann, et al.
Digestion
|
February 3, 2004
Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial
A Madisch, G Holtmann, G Mayr, et al.
The American Journal of Physiology
|
August 1, 1997
Survival of human pancreatic enzymes during small bowel transit: effect of nutrients, bile acids, and enzymes
G Holtmann, D G Kelly, B Sternby, et al.
Digestion
|
November 2, 2011
Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein β3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?
G Holtmann, C van Rensburg, T Schwan, et al.
Zeitschrift Fur Gastroenterologie
|
September 18, 2003
Persistently altered visceral perception after resection of an esophageal granular cell myoblastoma: a therapeutic concept revisited
A Canbay, R K Gieseler, P Hoffmann, et al.
Alimentary Pharmacology & Therapeutics
|
March 6, 2002
A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease
G Holtmann, P Bytzer, M Metz, et al.
Alimentary Pharmacology & Therapeutics
|
January 13, 2005
Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation
S Müller-Lissner, G Holtmann, P Rueegg, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 144) with videos related to
Sort By:
Page
of 15
Alimentary Pharmacology & Therapeutics
|
August 29, 2002
A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia
G Holtmann, J Gschossmann, P Mayr, et al.
Gut
|
June 9, 1998
Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia
G Holtmann, H Goebell, F Jockenhoevel, et al.
Digestive Diseases and Sciences
|
August 2, 2001
H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor?
G Holtmann, J Gschossmann, M Holtmann, et al.
The Journal of Urology
|
April 1, 1995
Report of a case with giant condyloma (Buschke-Löwenstein tumor) localized in the bladder
A Wiedemann, W P Diekmann, G Holtmann, et al.
Digestion
|
February 3, 2004
Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial
A Madisch, G Holtmann, G Mayr, et al.
The American Journal of Physiology
|
August 1, 1997
Survival of human pancreatic enzymes during small bowel transit: effect of nutrients, bile acids, and enzymes
G Holtmann, D G Kelly, B Sternby, et al.
Digestion
|
November 2, 2011
Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein β3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?
G Holtmann, C van Rensburg, T Schwan, et al.
Zeitschrift Fur Gastroenterologie
|
September 18, 2003
Persistently altered visceral perception after resection of an esophageal granular cell myoblastoma: a therapeutic concept revisited
A Canbay, R K Gieseler, P Hoffmann, et al.
Alimentary Pharmacology & Therapeutics
|
March 6, 2002
A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease
G Holtmann, P Bytzer, M Metz, et al.
Alimentary Pharmacology & Therapeutics
|
January 13, 2005
Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation
S Müller-Lissner, G Holtmann, P Rueegg, et al.
Page
of 15